Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2023-08-31 Major Shareholding Noti…
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 0053L' and contains the standard disclaimer language indicating it is provided by 'RNS, the news service of the London Stock Exchange.' The content itself is a 'TR-1: Standard form for notification of major holdings,' detailing changes in voting rights crossing a threshold (from 12.78% to 14.06%). This type of mandatory disclosure regarding significant changes in share ownership falls under the category of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific and appropriate classification for this content type.
2023-08-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is identified by the header 'RNS Number : 4655K' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'TR-1: Standard form for notification of major holdings' concerning an acquisition or disposal of voting rights by a shareholder (Dr Alexandre Akoulitchev), crossing a threshold. This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-08-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 1194K' and contains the header 'National Storage Mechanism'. The content is a 'TR-1: Standard form for notification of major holdings', detailing changes in voting rights percentage (from 9.94% to 8.31%) held by Unicorn Asset Management Limited in Oxford BioDynamics plc. This type of filing, which reports changes in significant share ownership thresholds, corresponds directly to the Major Shareholding Notification category. Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2023-08-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains an 'RNS Number'. It details changes in voting rights percentages (crossing the 5% threshold, moving from 6.82% to 9.94%) held by Unicorn Asset Management Limited in Oxford BioDynamics PLC. This structure and content perfectly match the definition of a Major Shareholding Notification, which is classified under the code MRQ.
2023-08-22 English
Result of General Meeting
Director's Dealing Classification · 98% confidence The document is an RNS announcement from Oxford BioDynamics PLC dated August 18, 2023. The primary content reports the 'Result of General Meeting' where all resolutions were passed, followed by details regarding the admission to trading of new Ordinary Shares resulting from a fundraising effort. Crucially, the document then transitions into detailed tables reporting 'Director/PDMR Dealings' for several executives (Matthew Wakefield, Jon Burrows, Alexandre Akoulitchev, Paul Stockdale, etc.) following the fundraising. The structure, the mention of 'RNS Number', and the specific reporting of insider transactions (Director/PDMR Dealings) strongly indicate a regulatory filing focused on insider trading disclosure, which falls under the category of Director's Dealing (DIRS). While it also mentions the result of a General Meeting (which could suggest AGM-R or DVA), the extensive detail dedicated to the share purchases by PDMRs makes DIRS the most specific and accurate classification for the core actionable information presented.
2023-08-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured data fields typical of regulatory filings concerning changes in share ownership thresholds. Specifically, it details the 'Resulting situation' of voting rights held by 'ODEY ASSET MANAGEMENT LLP' in 'Oxford BioDynamics PLC', crossing a threshold on 7/8/2023. This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the content is specific enough to warrant the MRQ classification over the general RNS fallback.
2023-08-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.